
|Articles|November 1, 2006
Breast cancer risk in subset of OC users
Oral contraceptives (OCs) are associated with a small increase in premenopausal breast cancer risk, especially in parous women who use them for 4 or more years before a first full-term pregnancy, according to a new meta-analysis.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA working with manufacturers to increase access to estradiol transdermal patches
2
Positively Pregnant tool helps patients time home pregnancy testing
3
ACOG's 2026-27 respiratory vaccine guidance, estradiol patch supply update, and more
4
David Shalowitz, MD, on strengthened evidence behind salpingectomy for ovarian cancer prevention
5





